CClinicalTrials.gg
Not yet recruitingNCT07666737Updated Jun 24, 2026

The Effect of Pericapsular Nerve Group Block With Different Local Anesthetic Volumes

An interventional study of pericapsular nerve group (PENG) block in Pericapsuler Nerve Group Block and Postoperative Pain, sponsored by Selcuk University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Early postoperative pain following shoulder surgery is a significant clinical problem for both patients and orthopedic surgeons. Effective pain control is crucial for improving postoperative comfort and optimizing rehabilitation. Pericapsular nerve group block (PENG) is a regional anesthesia method that has recently gained attention due to its lack of motor block and absence of pulmonary complications. The aim of this study is to evaluate the effect of PENG block, applied at two different volumes, on postoperative pain and opioid consumption in patients undergoing arthroscopic shoulder surgery.

02

Conditions studied

  • Pericapsuler Nerve Group Block
  • Postoperative Pain

Browse trials for

Keywords

  • arthroscopic shoulder surgery
  • postoperative pain
  • pericapsular nerve group block
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • elective arthroscopic shoulder surgery planned
  • ASA I-III physical status

Exclusion Criteria: Patients with

  • coagulopathy,
  • neuropathy,
  • anticoagulant use
  • history of chronic pain,
  • pre-existing psychiatric illness
  • body mass index greater than 35 kg/m2
  • allergy or sensitivity to local anesthetics and opiods
  • infection at the injection site
  • who cannot understand pain scoring
  • whose follow-up and treatment are continuing in the intensive care unit
  • who will undergo open shoulder surgery.
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Group I; PENG block, 20 mL 0.5% bupivacaine

    Procedure: pericapsular nerve group (PENG) block

  • Active comparator
    Group II; PENG block, 40ml 0.25% bupivacaine

    Procedure: pericapsular nerve group (PENG) block

Interventions

  • Procedurepericapsular nerve group (PENG) block

    During PENG block application; the patient's arm was rotated externally and abducted at 45 degrees. A longitudinal linear ultrasound probe was placed between the coracoid and humeral head. After identifying the humeral head, the tendon of the subscapular muscle, and the deltoid muscle above it, a 50 mm needle was inserted using the "in-plane" technique. After the needle tip was placed above the bone below the subscapularis tendon, a local anesthetic solution was injected.

05

What researchers measure

Primary outcomes

  1. postoperative pain and opiod consumption

    Time frame: postoperative 24 hours

06

Study locations

No study locations are listed for this record.

07

Registry details

Key details

Study ID
NCT07666737
Lead sponsor
Selcuk University
Responsible party
EMİNE ASLANLAR (associated professor, Selcuk University) — Principal investigator
First posted
Jun 24, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Feb 1, 2027 (estimated)
Last update
Jun 24, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion